No trading implication; this is a clerical correction. Monitor the upcoming annual meeting for any substantive governance discussions or updates on clinical development.
Price Chart
Executive Summary
Nuvation Bio Inc. filed a supplemental proxy statement to correct a typographical error in the non-employee director compensation table, updating Robert Mashal, M.D.'s cash compensation from $37,500 to $47,500. The filing is routine and does not impact corporate governance, strategy, or financials.
Key Financial Metrics
Key Facts
- Filing is a supplement to correct a typo in director compensation disclosure.
- Robert Mashal, M.D.'s cash compensation was corrected from $37,500 to $47,500 for fiscal year 2025.
- Total compensation for Dr. Mashal is now $432,500, up from previously reported $422,500.
- No other changes were made to the original proxy statement.
- The annual shareholder meeting is scheduled for May 21, 2026.
Financial Impact
Minimal; correction increases disclosed cash compensation by $10,000 for one director in 2025.
Risk Factors
- None material; this is a non-substantive correction.
- Perception of weak internal controls if frequent disclosure errors occur, though isolated incident appears benign.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-015827 |
| Document: 0001140361-26-015827-index-headers.html | 0001140361-26-015827 |
| Document: 0001140361-26-015827-index.html | 0001140361-26-015827 |
| Document: 0001140361-26-015827.txt | 0001140361-26-015827 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 4d ago | Press Release | $4.70 | awaiting T+60 | — | $4.57 (−2.87%) |
Aug 6, 2026 11w ago | 8-K | $6.11 | awaiting T+60 | — | $4.57 (−25.29%) |
Jun 26, 2026 17w ago | 424B5 | $5.61 $6.10 | ▼ −8.73% | ▼ −4.35% | $4.57 (+18.63%) |
Jun 23, 2026 17w ago | 144 | $6.46 $6.07 | ▲ +6.04% | ▲ +8.88% | $4.57 (+29.33%) |
Jun 23, 2026 17w ago | 144 | $6.46 $6.07 | ▼ −6.04% | ▼ −8.88% | $4.57 (−29.33%) |
May 4, 2026 24w ago | 8-K | $4.83 $6.70 | ▲ +38.72% | ▲ +35.98% | $4.57 (−5.49%) |
Apr 21, 2026 26w ago | DEFA14A | $5.11 $5.64 | ▲ +10.37% | ▲ +3.47% | $4.57 (−10.67%) |
Apr 17, 2026 27w ago | 144 | $5.12 $5.90 | ▲ +15.23% | ▲ +8.46% | $4.57 (−10.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers